Cost Savings in Chronic Pain Patients Initiating Peripheral Nerve Stimulation (PNS) with a 60-Day PNS Treatment
The findings suggest that, when PNS for chronic pain is warranted, initiating PNS with a 60-day treatment is more cost-effective than utilizing a brief conventional trial.
Authors
- Candace Gunnarsson (ORCID: https://orcid.org/0000-0003-0723-585X)
- Konstantin V. Slavin (ORCID: https://orcid.org/0000-0002-7946-8639)
- Nathan D. Crosby (ORCID: https://orcid.org/0000-0001-6181-0806)
- Kevin E. Vorenkamp (ORCID: https://orcid.org/0000-0001-8416-7964)
- Mark Stultz
- Hemant Kalia (ORCID: https://orcid.org/0000-0001-9033-9080)
- Andrew J. Epstein (ORCID: https://orcid.org/0000-0001-5078-6564)
- Jonathan M. Hagedorn (ORCID: https://orcid.org/0000-0003-1039-8166)
- David Dickerson (ORCID: https://orcid.org/0000-0002-8869-497X)
- Eric L. Keuffel (ORCID: https://orcid.org/0000-0001-5350-2272)
Institutions
- Duke University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Clinton Health Access Initiative (US)
- Sprint PNS System (United States) (US)
- Mayo Clinic in Arizona (US)
- Jesse Brown VA Medical Center (US)
- Center for Innovation (US)
Publication Details
- Journal
- Pain and Therapy
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1007/s40122-024-00677-4
- Citations
- 3
- Primary Topic
- Pain Management and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.92
Funders
- SPR Therapeutics